𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice

✍ Scribed by Lambert-Niclot, S.; Masquelier, B.; Cohen Codar, I.; Soulie, C.; Delaugerre, C.; Morand-Joubert, L.; Charpentier, C.; Ferre, V.; Plantier, J.-C.; Montes, B.; Carret, S.; Perrot, V.; Peytavin, G.; Costagliola, D.; Calvez, V.; Marcelin, A.-G.

Book ID
115473035
Publisher
Oxford University Press
Year
2012
Tongue
English
Weight
239 KB
Volume
67
Category
Article
ISSN
0305-7453

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Low rate of virological failure and main
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice
✍ Mattia C.F. Prosperi; Maurizio Zazzi; Grazia Punzi; Laura Monno; Grazia Colao; P πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 144 KB

## Abstract Protease inhibitor (PI)‐resistant HIV‐1 has hardly ever been detected at failed boosted PI‐based first‐line antiretroviral regimens in clinical trials. However, this phenomenon has not been investigated in clinical practice. To address this gap, data from patients starting a first‐line